14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Hyperhomocysteinemia in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Hyperhomocysteinemia: Condition in which the plasma levels of homocysteine and related metabolites are elevated (
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperhomocysteinemia is a risk factor of atherogenesis." | 3.78 | Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. ( Chen, Y; Hammock, BD; Kong, W; Xie, X; Zhang, D; Zhu, Y, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, D | 1 |
| Xie, X | 1 |
| Chen, Y | 1 |
| Hammock, BD | 1 |
| Kong, W | 1 |
| Zhu, Y | 1 |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Hyperhomocysteinemia
| Article | Year |
|---|---|
Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.
Topics: 8,11,14-Eicosatrienoic Acid; Activating Transcription Factor 6; Animals; Aorta; Base Sequence; DNA M | 2012 |